blog

Maintaining Clinical Trial Momentum during COVID-19 and Beyond

By Elizabeth Gargill on Thu, Apr 23, 2020 | 1 min read

In our latest Pharma15 Live! COVID-19 special report, BBK's President Matt Kibby introduces a new framework for helping clinical trial sponsors maintain study momentum during COVID-19 and beyond.

The framework features strategies for minimizing disruption during four key stages of the study lifecycle.

Topics: Patient Engagement, Patient Enrollment, COVID-19, Coronavirus, Matt Kibby

Ramping Up Patient & Site Engagement during COVID-19

By Elizabeth Gargill on Tue, Apr 14, 2020 | 6 min read

 

Guidance to Help Respond to Immediate Challenges 

As the COVID-19 outbreak challenges clinical trial sponsors, we’ve identified efforts to support patient and site engagement -  helping to minimize clinical trial disruption and keep timelines intact. Some efforts respond to FDA guidance on conducting clinical trials during the COVID-19 pandemic while others respond to challenges introduced by travel restrictions, infection risks, enhanced site burden, and protocol deviations.

Topics: Patient Engagement, Site Engagement, RSG Arrive, COVID-19

Minimizing Clinical Trial Disruption from COVID-19

By Elizabeth Gargill on Thu, Apr 2, 2020 | 2 min read

 

We are closely monitoring the COVID-19 outbreak and its impact on clinical trial patient recruitment, engagement, and compliance. As the health and wellbeing of patients remains our priority, we’ve outlined key solutions clinical trial sponsors can quickly deploy to enhance compliance and ensure patients are able to continue with their clinical trial participation.

Topics: Patient Engagement, Patient Enrollment, COVID-19, FDA Guidance, Coronavirus, Joan F. Bachenheimer

5 Innovations Shaking Up Clinical Trial Patient Recruitment

By Elizabeth Gargill on Tue, Mar 10, 2020 | 4 min read

 

For clinical trial sponsors, staying on top of the latest innovations can be a challenge, especially in an industry historically slow to adapt to change. But experts warn of the risk of falling behind, especially in light of advancing technologies that are impacting clinical trial enrollment and engagement.

While you may not be ready to embrace the use of a virtual self-service hologram—greeting patients in the doctor’s office with information about a clinical trial—there are a few key innovations that all clinical trial sponsors should keep on their radar. Below, we highlight three that are driving significant change.

 

Topics: Wearables, Patient Experience, Voice Assistants, Patient Portals, Call Centers, At-home Visits, Clinical Trial Innovations

Latest “Study Voices” Survey Finds Unexpected Similarities Between Healthcare Consumers and Clinical Trial Participants

By Elizabeth Gargill on Thu, Feb 20, 2020 | 3 min read

 

Survey Results Empower Clinical Trial Sponsors with New Opportunities for Patient Engagement

Our latest "Study Voices" survey challenges the long-held belief that the clinical trial experience should be approached differently than the healthcare consumer experience. The latest “Study Voices” survey – part of an ongoing series of surveys designed to shed light on key clinical research trends – explores patient attitudes towards technology,  healthcare affordability, physician access, transparency, and quality of care. It features responses from 2,067 individuals – 63% of whom identify themselves as healthcare consumers and 38% of whom identify themselves as clinical trial participants. The research was spearheaded by BBK's MythBusters team of Aaron Fleishman, Matt Kibby, Jessica Kim, Maddy Johnson and Elizabeth Gargill.

Topics: Study Voices, MythBusters, Healthcare Consumer, Clinical Trial Participant

The Art and Science of Clinical Trial Feasibility

By Alexia Medici, Account Executive on Wed, Feb 12, 2020 | 2 min read

 

Determining site feasibility is something that most investigators and site coordinators are familiar with. However, once the questionnaire is filled out and provided back to the sponsor and/or CRO, sites may not be aware of the internal process a reviewing entity may have in evaluating the site’s feasibility for the study. As a former clinical research coordinator, I was curious about this. So, I decided to work with BBK's President Matt Kibby, who has been revolutionizing the site feasibility process for the past 20 years. Together, we worked to understand and provide greater context to current site staff regarding the way BBK views and evaluates sites for study feasibility.

Topics: Site Selection, Site Engagement, Patient Enrollment, Feasibility

BBK Worldwide Bolsters Its Award-Winning Creative Department with the Hiring of Pedro Giesta as Designer

By Elizabeth Gargill on Mon, Feb 10, 2020 | 1 min read

 

We're very pleased to announce the hiring of Pedro Giesta as designer. With a talent for cutting-edge creative and insightful design, Giesta joins a team of award-winning designers and copywriters who push the industry forward with innovative and imaginative solutions. In his new position, Giesta will support concept development through creative execution – leveraging his experience as a studio artist, production artist, and graphic designer in the process.

Topics: Creative, Design, Employees

We're Packing Our Bags for SCOPE . . .

By Elizabeth Gargill on Wed, Feb 5, 2020 | 7 min read

 

. . . and heading south to the Sunshine State! This years marks our 11th straight year participating in the Summit for Clinical Ops Executives (SCOPE) – an event that always pushes the industry forward with thoughtful, informed dialogue.

This year SCOPE takes place February 18-21, 2020 in Orlando. The summit features four days of in-depth discussions in twenty different conferences, three plenary keynote sessions, the annual Participant Engagement Awards, and the ever-popular interactive breakout discussions.

We recently sat down with the summit's organizers – Micah Lieberman, Kaitlin Kelleher, and Marina Filshtinsky – to learn more about SCOPE and what they have in store for this year’s event. And don’t worry – if you haven’t attended SCOPE before, they share a few insights on why you might want to consider it.

Topics: Conferences, SCOPE, Events, 2020 Events, Cambridge Healthtech Institute, Clinical Operations

3 Myths That May Be Sabotaging Your Clinical Trial Enrollment Effort

By Elizabeth Gargill on Fri, Jan 24, 2020 | 4 min read

 

Myths are stubborn, persistent, and can easily put your well-intentioned clinical trial enrollment efforts at risk. But spotting and correcting them can be a challenge. To help the industry discern fact from fiction, we assembled our own MythBusters team, dedicated to confirming or busting common clinical trial myths. Empowered with data from our industry-wide surveys of patients, physicians, and clinical trial sponsors, the team identifies pervasive myths, puts them to the test, and arrives at a verdict.

Topics: Patient Engagement, Patient Experience, Study Voices, MythBusters, Patient Enrollment

2020: A Look Inside Our Crystal Ball

By Elizabeth Gargill on Thu, Dec 19, 2019 | 4 min read

 

In this special year end post, we asked a few of our BBK industry experts to comment on the clinical research landscape and to share their predictions for 2020.

Sarah Mandracchia, Director, Site Operations

Where do you see clinical trial patient travel going in 2020? 

I predict that 2020 will be a year of transformation for travel in the clinical trial space. In the last six months, we have seen a dramatic shift in our sponsors’ understanding of their patients’ needs related to travel, and more in-depth language included in informed consent forms (ICFs). This growing understanding of their patients, and the possible travel offerings, then resonates with their sites, which, in turn, feel even more supported during clinical trial administration.

Topics: BBK Worldwide, Patient Engagement, Patient Experience, 2020, Patient Enrollment

 
Subscribe To Our Blog